cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.8fqtbd
title: Occurrence Download

description: A dataset containing 122 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Schizothorax progastus (McClelland, 1839)"
 ]
}

 The dataset includes 122 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038096-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.gzm6fw
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Oenothera albisubcurva Renner)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "HasGeospatialIssue is false",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Specimen)"
 ]
 }
 }
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038098-240626123714530/datasets/export for details.
DOI: 10.15468/dl.bck9a2
title: Occurrence Download

description: A dataset containing 15923 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Oenothera parviflora L.)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "HasGeospatialIssue is false",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Specimen)"
 ]
 }
 }
 ]
}

 The dataset includes 15923 records from 138 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038099-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fw79yn
title: Occurrence Download

description: A dataset containing 199 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Leptaulus grandifolius Engl."
 ]
}

 The dataset includes 199 records from 26 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038100-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9b3vym
title: Occurrence Download

description: A dataset containing 98 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Oenothera capillifolia subsp. capillifolia)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "HasGeospatialIssue is false",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Specimen)"
 ]
 }
 }
 ]
}

 The dataset includes 98 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038101-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.xap6ng
title: Occurrence Download

description: A dataset containing 24 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Pyrenacantha cordicula Villiers"
 ]
}

 The dataset includes 24 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038102-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.sfy7p7
title: Occurrence Download

description: A dataset containing 10 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Ecuador",
 "TaxonKey is Steno bredanensis (G.Cuvier, 1828)"
 ]
}

 The dataset includes 10 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038103-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.zpx9jr
title: Occurrence Download

description: A dataset containing 84 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Ecuador",
 "TaxonKey is Stenella longirostris (Gray, 1828)"
 ]
}

 The dataset includes 84 records from 18 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038104-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.5450302
title: Incidence, treatment and recurrence of endometriosis in a UK-based population analysis using data from The Health Improvement Network and the Hospital Episode Statistics database

description: <b>Purpose:</b> This retrospective study used medical records from The Health Improvement Network (THIN) and Hospital Episode Statistics (HES) database to evaluate endometriosis (incidence, treatment and need for recurrent invasive procedures) in the general UK population. <b>Materials and methods:</b> Women aged 12–54 years between January 2000 and December 2010, with a Read code for endometriosis, were identified in THIN. Cases were validated by manual review of free-text comments in medical records and responses to physician questionnaires. False-negative cases were identified among women with Read codes for hysterectomy or dysmenorrhea. Prescriptions of medical therapies for endometriosis were identified in THIN. Cases of single and recurrent invasive procedures were identified in women with medical records in both THIN and HES. <b>Results:</b> Overall, 5087 women had a Read code for endometriosis, corresponding to an incidence of 1.02 (95% confidence interval [CI]: 0.99–1.05) per 1000 person-years. After case validation, the estimate was 1.46 (95% CI: 1.43–1.50) per 1000 person-years. Medical therapy was prescribed to 55.5% of women with endometriosis in the first year after diagnosis. In total, 48.3% of women received invasive treatment during the study period; approximately one-fifth of these women required further invasive treatment, mainly in the 3 years after the index procedure. <b>Conclusions:</b> Using Read codes as the only method to identify women with endometriosis underestimates incidence. Over half of women with recorded endometriosis are prescribed medical therapy in the first year after diagnosis. Women with diagnosed endometriosis are at risk of requiring recurrent invasive procedures.
DOI: 10.6084/m9.figshare.5450302.v1
title: Incidence, treatment and recurrence of endometriosis in a UK-based population analysis using data from The Health Improvement Network and the Hospital Episode Statistics database

description: <b>Purpose:</b> This retrospective study used medical records from The Health Improvement Network (THIN) and Hospital Episode Statistics (HES) database to evaluate endometriosis (incidence, treatment and need for recurrent invasive procedures) in the general UK population. <b>Materials and methods:</b> Women aged 12–54 years between January 2000 and December 2010, with a Read code for endometriosis, were identified in THIN. Cases were validated by manual review of free-text comments in medical records and responses to physician questionnaires. False-negative cases were identified among women with Read codes for hysterectomy or dysmenorrhea. Prescriptions of medical therapies for endometriosis were identified in THIN. Cases of single and recurrent invasive procedures were identified in women with medical records in both THIN and HES. <b>Results:</b> Overall, 5087 women had a Read code for endometriosis, corresponding to an incidence of 1.02 (95% confidence interval [CI]: 0.99–1.05) per 1000 person-years. After case validation, the estimate was 1.46 (95% CI: 1.43–1.50) per 1000 person-years. Medical therapy was prescribed to 55.5% of women with endometriosis in the first year after diagnosis. In total, 48.3% of women received invasive treatment during the study period; approximately one-fifth of these women required further invasive treatment, mainly in the 3 years after the index procedure. <b>Conclusions:</b> Using Read codes as the only method to identify women with endometriosis underestimates incidence. Over half of women with recorded endometriosis are prescribed medical therapy in the first year after diagnosis. Women with diagnosed endometriosis are at risk of requiring recurrent invasive procedures.
DOI: 10.15468/dl.5nue7b
title: Occurrence Download

description: A dataset containing 52 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Oenothera biennis var. biennis)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "HasGeospatialIssue is false",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Specimen)"
 ]
 }
 }
 ]
}

 The dataset includes 52 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038105-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.21250570
title: Systematic review of postpartum and pregnancy-related cervical artery dissection

description: Cervical artery dissection (CeAD) is responsible of one fifth of cases of ischemic stroke, but is uncommon during pregnancy or the early postpartum period and evidence is derived from published case reports and case series. This systematic review with a prospectively registered protocol was conducted to study the clinical presentation, management and prognosis of this condition. Ovid-Medline, PubMed Central, and CINAHL were searched without language restriction. Fifty-seven articles (50 case reports and seven case series) reporting on 77 patients were included. The mean age was 33.7 years. The main possible risk factors identified were migraine, hyperlipidemia, connective tissue disorders, preeclampsia and eclampsia, HELLP syndrome and prolonged second stage of labor. Headache was the most frequent symptom, followed by neck pain. Acute medical treatments included anticoagulation, antiplatelets, and endovascular therapy. No patients received thrombolysis. The overall prognosis was good with 77.8% of patients making full clinical recovery. Cervical artery dissection is a rare, but an important complication of pregnancy and puerperium. Diagnosis requires a high index of suspicion. The strong association with hypertensive and connective tissue disorders requires further research
DOI: 10.6084/m9.figshare.21250570.v1
title: Systematic review of postpartum and pregnancy-related cervical artery dissection

description: Cervical artery dissection (CeAD) is responsible of one fifth of cases of ischemic stroke, but is uncommon during pregnancy or the early postpartum period and evidence is derived from published case reports and case series. This systematic review with a prospectively registered protocol was conducted to study the clinical presentation, management and prognosis of this condition. Ovid-Medline, PubMed Central, and CINAHL were searched without language restriction. Fifty-seven articles (50 case reports and seven case series) reporting on 77 patients were included. The mean age was 33.7 years. The main possible risk factors identified were migraine, hyperlipidemia, connective tissue disorders, preeclampsia and eclampsia, HELLP syndrome and prolonged second stage of labor. Headache was the most frequent symptom, followed by neck pain. Acute medical treatments included anticoagulation, antiplatelets, and endovascular therapy. No patients received thrombolysis. The overall prognosis was good with 77.8% of patients making full clinical recovery. Cervical artery dissection is a rare, but an important complication of pregnancy and puerperium. Diagnosis requires a high index of suspicion. The strong association with hypertensive and connective tissue disorders requires further research
DOI: 10.6084/m9.figshare.21365783
title: Device positioning with LISA vs. INSURE: a crossover randomized controlled manikin trial

description: We aimed to compare time of device positioning, success of procedure and operator’s opinion with LISA vs. INSURE in a manikin simulating an extremely low birthweight infant. A randomized controlled crossover (AB/BA) trial of surfactant administration with LISA vs. INSURE in a preterm manikin. Forty-two tertiary hospital consultants and pediatric residents with previous experience with LISA and INSURE participated. The primary outcome measure was the time of device positioning. The secondary outcome measures were: success of the first attempt, number of attempts, correct depth, and participant’s opinion on difficulty in using the device. Median time of device positioning was shorter with LISA vs. INSURE (median difference −8 s, 95% confidence interval −16 to −1 s; <i>p</i> = .04). Success at first attempt was 35/40 with LISA (83%) and 31/40 with INSURE (74%) (<i>p</i> = .42). Median number of attempts was 1 (IQR 1–1) with LISA and 1 (IQR 1–2) with INSURE (<i>p</i> = .08). Correct depth was achieved in 30/40 with LISA (71%) and 37/40 with INSURE (88%) (<i>p</i> = .12). Participants found LISA easier to insert in the trachea (<i>p</i> = .002) but INSURE easier to place at the correct depth (<i>p</i> = .008). Handling the device (<i>p</i> = .43), visualizing the glottis (<i>p</i> = .17) and overall difficulty in using the device (<i>p</i> = .13) were not statistically different. In a preterm manikin model, positioning a thin catheter (LISA) was quicker and easier than a tracheal tube (INSURE), but the magnitude of the difference was unlikely to be clinically relevant and the tracheal tube was easier to place at the correct depth. clinicaltrial.gov NCT04944108.
DOI: 10.6084/m9.figshare.21365783.v1
title: Device positioning with LISA vs. INSURE: a crossover randomized controlled manikin trial

description: We aimed to compare time of device positioning, success of procedure and operator’s opinion with LISA vs. INSURE in a manikin simulating an extremely low birthweight infant. A randomized controlled crossover (AB/BA) trial of surfactant administration with LISA vs. INSURE in a preterm manikin. Forty-two tertiary hospital consultants and pediatric residents with previous experience with LISA and INSURE participated. The primary outcome measure was the time of device positioning. The secondary outcome measures were: success of the first attempt, number of attempts, correct depth, and participant’s opinion on difficulty in using the device. Median time of device positioning was shorter with LISA vs. INSURE (median difference −8 s, 95% confidence interval −16 to −1 s; <i>p</i> = .04). Success at first attempt was 35/40 with LISA (83%) and 31/40 with INSURE (74%) (<i>p</i> = .42). Median number of attempts was 1 (IQR 1–1) with LISA and 1 (IQR 1–2) with INSURE (<i>p</i> = .08). Correct depth was achieved in 30/40 with LISA (71%) and 37/40 with INSURE (88%) (<i>p</i> = .12). Participants found LISA easier to insert in the trachea (<i>p</i> = .002) but INSURE easier to place at the correct depth (<i>p</i> = .008). Handling the device (<i>p</i> = .43), visualizing the glottis (<i>p</i> = .17) and overall difficulty in using the device (<i>p</i> = .13) were not statistically different. In a preterm manikin model, positioning a thin catheter (LISA) was quicker and easier than a tracheal tube (INSURE), but the magnitude of the difference was unlikely to be clinically relevant and the tracheal tube was easier to place at the correct depth. clinicaltrial.gov NCT04944108.
DOI: 10.6084/m9.figshare.21767285
title: Comprehensive surgical staging for placenta accreta spectrum

description: To analyze how precise the surgical staging is after prenatal diagnosis of patients with placenta accreta spectrum (PAS). This was a retrospective cohort study that included 622 women diagnosed with placenta accreta spectrum who underwent surgery between 1 January 2000, and 1 January 2020, in public, private, and university hospitals in Buenos Aires, Argentina. Prenatal diagnosis included abdominal and transvaginal ultrasounds and T2-weighted MRI scans. Comprehensive surgical staging (CSS) was performed by dissecting the coalescence spaces of the pelvic fasciae, including the broad ligament and the colpouterine and retrouterine spaces. Once the compromised uterine wall (lateral, anterior or posterior) was identified, the characteristics of the lesion were evaluated. The lateral invasion was classified as type A when there was no placental tissue in the parametrial zone; type B when the placental tissue protruded laterally and was covered by serosa, and type C when the placental tissue included neoformed vessels. Involvement of the retrovesical space (anterior uterine wall) was classified as type A when no neoformed vessels and no firm adherence between nearby organs were present, type B when the retrovesical area partially adhered but the planes could be dissected, and type C when the lower dissection of the vesicouterine space was extremely adhered or impossible. The posterior uterine aspect was classified after exteriorizing the organ, with the placenta still inside. It was determined as type A when there was no evidence of placental invasion, type B when there was organ adherence or it showed a heterogeneous appearance of the posterior uterine wall above the peritoneal reflection, and type C when there was adherence to other organs or when the invasion or neovascularization was below the peritoneal reflection. CSS increases the efficacy of prenatal studies, including ultrasound and MRI, by up to 50%. The diagnosis of type 2 (parametrial) PAS or low retrovesical invasion implied an immediate modification of the surgical tactics, vascular control, or a specific type of surgery. Additionally, deep interfacial dissection allowed the identification of healthy uterine tissue, modifying the initial indication of hysterectomy for a conservative reconstructive procedure. Comprehensive surgical staging of PAS proved to be an excellent tool for determining the extent and specific topography of placental invasion
DOI: 10.6084/m9.figshare.21385614
title: Maternal hemoglobin levels and neonatal outcomes: the Japan Environment and Children’s Study

description: Low birth weight (LBW), small for gestational age (SGA), and preterm birth (PTB) are important neonatal outcomes that may affect infant morbidity and mortality. The aim of this study is to investigate associations between maternal hemoglobin (Hb) concentrations and pregnancy outcomes of LBW, SGA, and PTB. This was a prospective birth cohort study using data of the Japan Environment and Children’s Study. Participants were divided into five groups according to maternal Hb (g/dL) in the first and second trimesters: group 1, Hb &lt; 9; group 2, 9 ≤ Hb &lt; 11.0; group 3, 11.0 ≤ Hb &lt; 13.0; group 4, 13.0 &lt; Hb &lt; 14.0; and group 5, 14.0 ≤ Hb. We examined the relationships between LBW, PTB, SGA, and maternal Hb in the first and second trimesters. Excluding 29,673, a total of 74,392 newborns (first trimester: <i>n</i> = 39,084, second trimester: <i>n</i> = 35,308) were included. We obtained adjusted odds ratios (aORs) (95% confidence intervals (CIs)) using multivariate analysis; compared with group 3 in the first trimesters, women in group 1 were at increased risk of PTB (aOR, 3.20; 95% CI, 1.69–6.09), LBW (aOR, 2.21; 95% CI, 1.19–4.09). In the second trimester, multivariate analysis revealed that, compared with group 3 in the second trimester, women in group 1 were at increased risk of PTB (aOR, 2.30; 95% CI, 1.19–4.42) and women in group 5 were at increased risk of LBW (aOR, 1.87; 95% CI, 1.24–2.81) and PTB (aOR, 1.73; 95% CI, 1.06–2.83). Elevated maternal Hb in the second trimester was associated with risks of PTB and LBW.
DOI: 10.6084/m9.figshare.21385614.v1
title: Maternal hemoglobin levels and neonatal outcomes: the Japan Environment and Children’s Study

description: Low birth weight (LBW), small for gestational age (SGA), and preterm birth (PTB) are important neonatal outcomes that may affect infant morbidity and mortality. The aim of this study is to investigate associations between maternal hemoglobin (Hb) concentrations and pregnancy outcomes of LBW, SGA, and PTB. This was a prospective birth cohort study using data of the Japan Environment and Children’s Study. Participants were divided into five groups according to maternal Hb (g/dL) in the first and second trimesters: group 1, Hb &lt; 9; group 2, 9 ≤ Hb &lt; 11.0; group 3, 11.0 ≤ Hb &lt; 13.0; group 4, 13.0 &lt; Hb &lt; 14.0; and group 5, 14.0 ≤ Hb. We examined the relationships between LBW, PTB, SGA, and maternal Hb in the first and second trimesters. Excluding 29,673, a total of 74,392 newborns (first trimester: <i>n</i> = 39,084, second trimester: <i>n</i> = 35,308) were included. We obtained adjusted odds ratios (aORs) (95% confidence intervals (CIs)) using multivariate analysis; compared with group 3 in the first trimesters, women in group 1 were at increased risk of PTB (aOR, 3.20; 95% CI, 1.69–6.09), LBW (aOR, 2.21; 95% CI, 1.19–4.09). In the second trimester, multivariate analysis revealed that, compared with group 3 in the second trimester, women in group 1 were at increased risk of PTB (aOR, 2.30; 95% CI, 1.19–4.42) and women in group 5 were at increased risk of LBW (aOR, 1.87; 95% CI, 1.24–2.81) and PTB (aOR, 1.73; 95% CI, 1.06–2.83). Elevated maternal Hb in the second trimester was associated with risks of PTB and LBW.
DOI: 10.6084/m9.figshare.21767285.v1
title: Comprehensive surgical staging for placenta accreta spectrum

description: To analyze how precise the surgical staging is after prenatal diagnosis of patients with placenta accreta spectrum (PAS). This was a retrospective cohort study that included 622 women diagnosed with placenta accreta spectrum who underwent surgery between 1 January 2000, and 1 January 2020, in public, private, and university hospitals in Buenos Aires, Argentina. Prenatal diagnosis included abdominal and transvaginal ultrasounds and T2-weighted MRI scans. Comprehensive surgical staging (CSS) was performed by dissecting the coalescence spaces of the pelvic fasciae, including the broad ligament and the colpouterine and retrouterine spaces. Once the compromised uterine wall (lateral, anterior or posterior) was identified, the characteristics of the lesion were evaluated. The lateral invasion was classified as type A when there was no placental tissue in the parametrial zone; type B when the placental tissue protruded laterally and was covered by serosa, and type C when the placental tissue included neoformed vessels. Involvement of the retrovesical space (anterior uterine wall) was classified as type A when no neoformed vessels and no firm adherence between nearby organs were present, type B when the retrovesical area partially adhered but the planes could be dissected, and type C when the lower dissection of the vesicouterine space was extremely adhered or impossible. The posterior uterine aspect was classified after exteriorizing the organ, with the placenta still inside. It was determined as type A when there was no evidence of placental invasion, type B when there was organ adherence or it showed a heterogeneous appearance of the posterior uterine wall above the peritoneal reflection, and type C when there was adherence to other organs or when the invasion or neovascularization was below the peritoneal reflection. CSS increases the efficacy of prenatal studies, including ultrasound and MRI, by up to 50%. The diagnosis of type 2 (parametrial) PAS or low retrovesical invasion implied an immediate modification of the surgical tactics, vascular control, or a specific type of surgery. Additionally, deep interfacial dissection allowed the identification of healthy uterine tissue, modifying the initial indication of hysterectomy for a conservative reconstructive procedure. Comprehensive surgical staging of PAS proved to be an excellent tool for determining the extent and specific topography of placental invasion